TY - JOUR
T1 - Casting, taping or stretching after botulinum toxin type A for spastic equinus foot
T2 - A single-blind randomized trial on adult stroke patients
AU - Carda, Stefano
AU - Invernizzi, Marco
AU - Baricich, Alessio
AU - Cisari, Carlo
N1 - Funding Information:
Dr Stefano Carda has received lecture fees from Ipsen and Allergan. Professor Carlo Cisari has received grant support from Ipsen, Allergan and Merz.
PY - 2011/12
Y1 - 2011/12
N2 - Objective: To investigate the effect of different adjunctive treatments after botulinum toxin type A.Design: Single-blind, randomized trial, with three-month follow-up.Setting: Secondary rehabilitative care.Subjects: Convenience sample of 69 chronic hemiplegic adult patients with spastic equinus foot.Interventions: Following botulinum toxin type A injection at the plantar flexors, patients were randomly assigned to three groups and treated with either taping, casting or stretching for one week, and with stretching and gait training for the next week.Outcome measures: Modified Ashworth Scale at plantar flexors, passive range of motion at the ankle, six-minute walking test, 10-metre walking test, Functional Ambulation Categories, ankle dorsiflexor strength were evaluated before treatment (t0) at 20 days (t1) and 90 days (t2) after treatment.Results: At t1 only the taping and casting groups showed significant improvements in Modified Ashworth Scale, six-minute walking test, 10-metre walking test and passive range of motion (P < 0.02). At t2, while the results were maintained in the casting group, only six-minute walking test and Modified Ashworth Scale were still significantly improved in the taping group. Ankle dorsiflexor strength and Functional Ambulation Categories did not change in any of the groups at any time. At t2 the casting group performed better than the taping and stretching groups at Modified Ashworth Scale and passive range of motion, and better than the stretching group at six-minute walking test (P < 0.02).Conclusions: Combining botulinum toxin type A to the ankle plantar flexors with casting or taping gives better and longer lasting results than with stretching alone.
AB - Objective: To investigate the effect of different adjunctive treatments after botulinum toxin type A.Design: Single-blind, randomized trial, with three-month follow-up.Setting: Secondary rehabilitative care.Subjects: Convenience sample of 69 chronic hemiplegic adult patients with spastic equinus foot.Interventions: Following botulinum toxin type A injection at the plantar flexors, patients were randomly assigned to three groups and treated with either taping, casting or stretching for one week, and with stretching and gait training for the next week.Outcome measures: Modified Ashworth Scale at plantar flexors, passive range of motion at the ankle, six-minute walking test, 10-metre walking test, Functional Ambulation Categories, ankle dorsiflexor strength were evaluated before treatment (t0) at 20 days (t1) and 90 days (t2) after treatment.Results: At t1 only the taping and casting groups showed significant improvements in Modified Ashworth Scale, six-minute walking test, 10-metre walking test and passive range of motion (P < 0.02). At t2, while the results were maintained in the casting group, only six-minute walking test and Modified Ashworth Scale were still significantly improved in the taping group. Ankle dorsiflexor strength and Functional Ambulation Categories did not change in any of the groups at any time. At t2 the casting group performed better than the taping and stretching groups at Modified Ashworth Scale and passive range of motion, and better than the stretching group at six-minute walking test (P < 0.02).Conclusions: Combining botulinum toxin type A to the ankle plantar flexors with casting or taping gives better and longer lasting results than with stretching alone.
KW - Botulinum toxin
KW - Casting
KW - Hemiplegia
KW - Spasticity
KW - stretching
UR - http://www.scopus.com/inward/record.url?scp=83455231477&partnerID=8YFLogxK
U2 - 10.1177/0269215511405080
DO - 10.1177/0269215511405080
M3 - Article
SN - 0269-2155
VL - 25
SP - 1119
EP - 1127
JO - Clinical Rehabilitation
JF - Clinical Rehabilitation
IS - 12
ER -